194 related articles for article (PubMed ID: 37638055)
1. Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein.
Romero MJ; Yue Q; Singla B; Hamacher J; Sridhar S; Moseley AS; Song C; Mraheil MA; Fischer B; Zeitlinger M; Chakraborty T; Fulton D; Gan L; Annex BH; Csanyi G; Eaton DC; Lucas R
Front Immunol; 2023; 14():1241448. PubMed ID: 37638055
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cells.
Yang K; Liu S; Yan H; Lu W; Shan X; Chen H; Bao C; Feng H; Liao J; Liang S; Xu L; Tang H; Yuan JX; Zhong N; Wang J
Signal Transduct Target Ther; 2023 Jul; 8(1):276. PubMed ID: 37452066
[TBL] [Abstract][Full Text] [Related]
3. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
[TBL] [Abstract][Full Text] [Related]
4.
Tiwari V
Biol Open; 2020 Oct; 9(10):. PubMed ID: 32878881
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
[TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
8. Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.
Yang LJ; Chen RH; Hamdoun S; Coghi P; Ng JPL; Zhang DW; Guo X; Xia C; Law BYK; Wong VKW
Phytomedicine; 2021 Jul; 87():153591. PubMed ID: 34029937
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
10. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
11. An efficient system to generate truncated human angiotensin converting enzyme 2 (hACE2) capable of binding RBD and spike protein of SARS-CoV2.
Gao X; Liang K; Mei S; Peng S; Vong EG; Zhan J
Protein Expr Purif; 2021 Aug; 184():105889. PubMed ID: 33852951
[TBL] [Abstract][Full Text] [Related]
12. Epithelial Sodium Channel-α Mediates the Protective Effect of the TNF-Derived TIP Peptide in Pneumolysin-Induced Endothelial Barrier Dysfunction.
Czikora I; Alli AA; Sridhar S; Matthay MA; Pillich H; Hudel M; Berisha B; Gorshkov B; Romero MJ; Gonzales J; Wu G; Huo Y; Su Y; Verin AD; Fulton D; Chakraborty T; Eaton DC; Lucas R
Front Immunol; 2017; 8():842. PubMed ID: 28785264
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
14. Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.
Lai YC; Cheng YW; Chao CH; Chang YY; Chen CD; Tsai WJ; Wang S; Lin YS; Chang CP; Chuang WJ; Chen LY; Wang YR; Chang SY; Huang W; Wang JR; Tseng CK; Lin CK; Chuang YC; Yeh TM
Front Immunol; 2022; 13():868724. PubMed ID: 35603169
[TBL] [Abstract][Full Text] [Related]
15. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2.
Miluzio A; Cuomo A; Cordiglieri C; Donnici L; Pesce E; Bombaci M; Conti M; Fasciani A; Terracciano L; Manganaro L; Toccafondi M; Scagliola A; Oliveto S; Ricciardi S; Grifantini R; De Francesco R; Abrignani S; Manfrini N; Biffo S
EBioMedicine; 2023 Jan; 87():104390. PubMed ID: 36584595
[TBL] [Abstract][Full Text] [Related]
16. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
17. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
18. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847
[TBL] [Abstract][Full Text] [Related]
19. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R; Murugan NA; Srivastava V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.
Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O
Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
